See more : Dr. Reddy’s Laboratories Limited (RDY) Income Statement Analysis – Financial Results
Complete financial analysis of Red White & Bloom Brands Inc. (RWB.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Red White & Bloom Brands Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Atlas Elevators General Trading and Contracting Co. (9578.SR) Income Statement Analysis – Financial Results
- Ercros, S.A. (ECR.MC) Income Statement Analysis – Financial Results
- dotdigital Group Plc (DOTD.L) Income Statement Analysis – Financial Results
- EUDA Health Holdings Limited (EUDAW) Income Statement Analysis – Financial Results
- SG Group Holdings Limited (1657.HK) Income Statement Analysis – Financial Results
Red White & Bloom Brands Inc. (RWB.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.redwhitebloom.com
About Red White & Bloom Brands Inc.
Red White & Bloom Brands Inc. engages in the cultivation and retail of cannabis products primarily in Michigan, California, Florida, and Oklahoma. The company is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 88.33M | 97.49M | 37.27M | 23.34M | 284.36K | 0.00 | 0.00 |
| Cost of Revenue | 58.85M | 69.87M | 14.05M | 9.98M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 29.49M | 27.63M | 23.22M | 13.35M | 284.36K | 0.00 | 0.00 |
| Gross Profit Ratio | 33.38% | 28.34% | 62.30% | 57.22% | 100.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 28.77M | 30.86M | 32.96M | 31.23M | 7.32M | 386.39K | 357.66K |
| Selling & Marketing | 1.78M | 3.87M | 2.73M | 1.76M | 913.41K | 1.67M | 0.00 |
| SG&A | 33.98M | 34.73M | 35.68M | 33.00M | 8.23M | 2.06M | 357.66K |
| Other Expenses | 3.78M | 7.23M | 21.01M | 15.29M | 1.90K | -7.45M | -32.42K |
| Operating Expenses | 37.76M | 41.96M | 56.70M | 48.29M | 8.23M | 7.45M | 32.42K |
| Cost & Expenses | 96.61M | 111.83M | 70.74M | 58.27M | 8.23M | 7.45M | 32.42K |
| Interest Income | 3.04M | 19.72M | 26.19M | 11.75M | 399.06K | 139.94K | 34.57K |
| Interest Expense | 33.50M | 24.50M | 23.96M | 5.27M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 5.42M | 7.78M | 21.01M | 10.87M | 1.90K | 2.06M | 357.66K |
| EBITDA | -77.59M | -207.26M | -12.47M | 5.92M | -8.23M | -7.83M | 325.24K |
| EBITDA Ratio | -87.84% | -8.96% | -73.71% | -82.34% | -856.47% | 0.00% | 0.00% |
| Operating Income | -8.27M | -14.33M | -33.48M | -34.93M | -8.23M | -7.45M | -32.42K |
| Operating Income Ratio | -9.37% | -14.70% | -89.84% | -149.68% | -2,894.57% | 0.00% | 0.00% |
| Total Other Income/Expenses | -108.24M | -224.97M | -5.51M | 13.01M | -4.28M | -377.27K | -34.57K |
| Income Before Tax | -116.51M | -247.23M | -38.99M | -21.70M | -12.51M | -7.83M | -32.42K |
| Income Before Tax Ratio | -131.90% | -253.59% | -104.62% | -92.96% | -4,400.74% | 0.00% | 0.00% |
| Income Tax Expense | 19.98M | -1.67M | 160.85K | -3.12M | 5.39M | 40.30K | -357.66K |
| Net Income | -138.90M | -245.56M | -39.15M | -18.58M | -17.91M | -7.83M | -32.42K |
| Net Income Ratio | -157.24% | -251.88% | -105.05% | -79.60% | -6,297.84% | 0.00% | 0.00% |
| EPS | -0.28 | -0.63 | -0.18 | -0.14 | -1.06 | -4.17 | -0.18 |
| EPS Diluted | -0.28 | -0.63 | -0.18 | -0.14 | -1.06 | -4.17 | -0.18 |
| Weighted Avg Shares Out | 469.94M | 392.44M | 217.80M | 137.57M | 16.94M | 1.88M | 177.73K |
| Weighted Avg Shares Out (Dil) | 469.94M | 392.44M | 217.80M | 137.57M | 16.94M | 1.88M | 177.73K |
Source: https://incomestatements.info
Category: Stock Reports